ArticleTransplantation and cellular therapy2026

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

Zachary D Crees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.